马方综合征患者全髋关节置换术:不良事件与5年翻修率
基于国家数据库的匹配队列研究,比较144例马方综合征患者与1440例非马方综合征患者行全髋关节置换术后的结局。马方综合征与更高的90天静脉血栓栓塞、心脏事件、肺炎和尿路感染风险独立相关,但5年翻修率无显著差异。
要点
- 马方综合征患者THA后90天静脉血栓栓塞、心脏事件、肺炎、尿路感染风险更高。
- 马方综合征与非马方综合征患者5年翻修率无显著差异。
- 识别出的高风险不良事件或有助于指导围手术期管理路径。
核心结论
- THA后马方综合征与多种90天不良事件风险升高独立相关,但5年翻修率未升高。
- 识别出的高风险不良事件可能帮助外科医生改进围手术期管理路径,同时对该罕见病人群THA的关节生存保有信心。
研究设计与样本
- 在国家数据库中识别接受THA的成年马方综合征患者和非马方综合征患者。
- 排除术前90天内诊断感染、创伤或肿瘤的患者。
- 按年龄、性别和合并症指数进行1:10匹配。
- 匹配后纳入144例马方综合征患者和1440例非马方综合征患者。
- 评估90天术后不良事件和5年翻修,分别采用多变量分析和对数秩检验进行比较。
主要发现
- 多变量分析显示马方综合征与更高的90天不良事件风险独立相关:静脉血栓栓塞事件(OR:2.9,P=.001)。
- 心脏事件(OR:4.5,P=.034)。
- 肺炎(OR:3.5,P<.001)。
- 尿路感染(OR:5.2,P<.001)。
- 5年翻修率无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Marfan syndrome is a rare inherited connective tissue disease, which may be present in patients who have advanced hip pathologies that may require total hip arthroplasty (THA). The postoperative course of patients who have Marfan syndrome following THA has not yet been defined. METHODS: Adult patients who have and do not have Marfan syndrome and underwent THA were identified in a national database. Patients diagnosed who had infection, trauma, or neoplasms within the 90 days prior to surgery were excluded. Those who have versus those who did not have Marfan syndrome were matched 1:10 based on age, sex, and a comorbidity index. After matching, 144 patients who have Marfan syndrome and 1,440 who do not have Marfan syndrome were identified. The 90-day postoperative adverse events and 5-year revisions were assessed and compared with multivariable analyses and log rank tests, respectively. RESULTS: Multivariable analyses demonstrated that Marfan syndrome was independently associated with greater odds of 90-day adverse events: venous thromboembolic events (odds ratio [OR]: 2.9, P = .001), cardiac events (OR: 4.5, P = .034), pneumonia (OR: 3.5, P < .001), and urinary tract infections (OR: 5.2, P < .001). There was no significant difference in 5-year rates of revision. CONCLUSIONS: Following THA, Marfan syndrome was independently associated with greater rates of several 90-day adverse events, but not higher 5-year rates of revision. The identified at-risk adverse events may help guide surgeons to improve perioperative care pathways, while having confidence regarding joint survival of THA in this rare disease population.
引用
- Day W, Jayaram RH, Rubin LE, et al. Total Hip Arthroplasty in Patients Who Have Marfan Syndrome: Adverse Events and 5-Year Revision Rates. J Arthroplasty. 2023. PMID: 37952742. doi:10.1016/j.arth.2023.10.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。